SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-22-016245
Filing Date
2022-03-30
Accepted
2022-03-30 17:16:36
Documents
8
Effectiveness Date
2022-03-30

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea157614-s8_biomxinc.htm S-8 39646
2 OPINION OF SULLIVAN & WORCESTER LLP ea157614ex5-1_biomx.htm EX-5.1 7492
3 CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A MEMBER ea157614ex23-2_biomx.htm EX-23.2 2242
4 CONSENT OF DELOITTE & TOUCHE LLP ea157614ex23-3_biomx.htm EX-23.3 4739
5 FILING FEE TABLE ea157614ex-fee_biomxinc.htm EX-FILING FEES 14523
6 GRAPHIC ex5-1_001.jpg GRAPHIC 6157
7 GRAPHIC ex5-1_002.jpg GRAPHIC 1755
8 GRAPHIC ex23-3_001.jpg GRAPHIC 4059
  Complete submission text file 0001213900-22-016245.txt   86658
Mailing Address 22 EINSTEIN ST., 5TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 5TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263995 | Film No.: 22787682
SIC: 2836 Biological Products, (No Diagnostic Substances)